MGRX

Mangoceuticals, Inc. Common Stock

0.38

USD

MGRX Earnings Reports

Positive Surprise Ratio

No Data Available for MGRX

Next Report

Date of Next Report

Mar 20, 2026

Estimate for Q4 25 (Revenue/ EPS)

Implied change from Q3 25 (Revenue/ EPS)

Implied change from Q4 24 (Revenue/ EPS)

Mangoceuticals, Inc. Common Stock earnings per share and revenue

On Nov 14, 2025, MGRX reported earnings of -0.69 USD per share (EPS) for Q3 25, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached 80.00 thousand, compared to an expected --, with a --% difference. The market reacted with a -14.86% price change (close before vs. close after earnings).

Looking ahead to Q4 25, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

FAQ

What were Mangoceuticals, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Mangoceuticals, Inc. Common Stock reported EPS of -$0.69, missing estimates by --, and revenue of $80.00K, -- -- expectations.

How did the market react to Mangoceuticals, Inc. Common Stock's Q3 2025 earnings?

The stock price moved down -14.86%, changed from $1.48 before the earnings release to $1.26 the day after.

When is Mangoceuticals, Inc. Common Stock expected to report next?

The next earning report is scheduled for Mar 20, 2026.

What are the forecasts for Mangoceuticals, Inc. Common Stock's next earnings report?

Based on -- analysts, Mangoceuticals, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.